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The capacity of immune complex deposition to
cause diffuse injury to the glomerular capillary ioop
walls has been recognized for some time [1]. Mor-
phologically, the reaction to such injury varies from
membranous glomerulopathy to proliferative glomer-
ulonephritis [1, 2]. In the former, thickening of the
loop walls by immune complex deposits and mem-
branous transformation is typical. In the latter, prolif-
eration of endothelial cells and, to a lesser degree, of
epithelial and mesangial cells is seen. In the most severe
lesions there is disruption of the basement membrane,
exudation of fibrin into Bowman's space and crescent
formation. The lesions are diffuse due to the uniform
distribution of immune complexes in the capillary loop
walls, as revealed by immunofluorescence [1] and elec-
tron microscopy [2]. Because of its prevalence in both
human disease and the experimental models initially
studied, it was generally accepted that this diffuse pat-
tern of tissue response was characteristic of all immune
complex-induced glomerulonephritis. However, re-
cently a second pattern of response has been observed
both in animals and in man [4]. This pattern (which we
have previously termed mesangiopathic glomerulone-
phritis [4]) is characterized by the primary deposition
of immune complexes in the mesangium, provoking a
proliferation of mesangial cells and matrix. To the ex-
tent that the deposits are confined to the mesangial
area, injury to the loop will be prevented. However, if
complexes are laid down so rapidly that their mass ex-
ceeds the capacity of the mesangium to accommodate
them, some will accumulate in the loop wall and pro-
duce local lesions. These may take the form of prolif-
erative or necrotizing glomerulitis [5]. Characteristi-
cally, the degree of loop involvement varies from
glomerulus to glomerulus as well as within different
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loops of the same glomerulus, so that the resulting pic-
ture is sometimes one of focal glomerulonephritis [5].
In order to explain how these two contrasting pat-
terns of response can both result from the glomerular
deposition of immune complexes, experiments were
performed in animals. Results of these experiments
suggest that the primary determinant of the site of
immune complex deposition, and therefore of the
pattern of tissue response, is the size of the immune
complex [6]. Thus, most rabbits given a single i.v. in-
jection of a large amount (0,5 g) of bovine serum albu-
min (BSA) will respond by forming predominantly
7S, IgG antibody to BSA. Because of the amount of
BSA initially injected, newly formed antibody will re-
act with residual antigen to form circulating complexes
with a mol wt of 300,000 to 500,000 daltons. Such
animals will show deposition of complexes in the gb-
merular loop and a diffuse gbomerulonephritis. How-
ever, an occasional rabbit will respond to identical
treatment by forming predominantly 19S, 1gM anti-
body to BSA. Such an animal will have circulating
complexes with a mol wt of 1,000,000 daltons or
greater, will show deposition of complexes predomi-
nantly in the mesangium, and may display a focal mes-
angiopathic glomerulonephritis [6}.
The chronic BSA model gives further information on
the relation between complex size and the site of
complex deposition [7]. In rabbits given daily injec-
tions of a moderate amount of BSA (12.5 mg) for a
prolonged period of time, the incidence and type of
ghirneruhir response to injury depend on the immune
complex size, which is a function of the extent of anti-
body formation. Those animals with a sustained low
level antibody response have circulating complexes
with mol wts of 500,000 to 700,000 daltons, have im-
mune complex deposits primarily in the loop wall and
display a diffuse gbomerubonephritis, whereas those
animals with a sustained intermediate-level antibody
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response have circulating complexes of 1,000,000 dal-
tons or more in mol wt, show immune complex deposi-
tion primarily in the mesangium and are found to have
focal mesangiopathic glomerulonephritis.
Taken together these experiments indicate that the
type of lesion is determined by the site of deposition of
the immune complexes, which, in turn, is a function of
their size. In addition to antibody mol wt and the ratio
of antibody to antigen, immune complex size can be
influenced by antibody avidity, antigen size and the in-
teraction of complexes with components of the com-
plement system or rheumatoid factors.
That it is the site of deposition of complexes rather
than their size per se which determines the type of the
tissue response is shown by experiments in which
moderate doses of cortisone are administered to rabbits
with circulating small-sized immune complexes [8]. As
a result of this treatment, the small complexes do not
penetrate the loop wall but, instead, accumulate in the
mesangium. Deposition in this site results in mesangio-
pathic changes such as are seen in an untreated animal
with intermediate-sized circulating complexes, rather
than the diffuse inflammatory response typically re-
sulting from the deposition of the smaller complexes in
the loop wall.
The mechanisms responsible for the differential dis-
tribution of immune complexes of differing sizes in
different parts of the glomerulus are largely unknown.
Small complexes apparently readily penetrate the loop
wall, undergo aggregation during their passage and
accumulate in the wall beneath the epithelial cells. Since
the loop wall ordinarily presents a barrier to the pas-
sage of molecules of this size, some factor or factors
must be responsible for the apparent ease with which
small complexes can traverse the wall. Several possi-
bilities have been suggested. Activation of complement
by the immune complexes may directly influence the
penetrability of the loop wall [9]. Alternately, chemo-
tactic factors generated as a consequence of comple-
ment activation may cause the accumulation of poly-
morphonuclear leucocytes in the vicinity of the im-
mune complexes. Enzymes released from the lysosomes
of such cells may increase the permeability of the wall
[10]. Regardless of the mechanism, the net result is
damage to the basement membrane which compro-
mises its function as a filtration barrier.
In contrast to small-sized complexes, intermediate
complexes do not penetrate the basement membrane
directly but are caught up in the mesangium, either by
phagocytosis directly from the lumen or by being
shunted from the subendothelial space [11]. Moderate
amounts of intermediate-sized complexes can be ac-
commodated by the mesangial system without provok-
ing any response aside from proliferation of mesangial
cells. With larger amounts of complexes, extension of
mesangial cells and matrix together with antigen-anti-
body deposits into the lumen and between the base-
ment membrane and the endothelial cells may
compromise the filtering ability of the capillary loop.
In addition, in these more exposed positions, the com-
plexes appear to provoke an inflammatory response
which is notably absent when the complexes are con-
fined to the centrilobular mesangial area.
In human disease there is little information available
about the relationship of immune complex size to the
distribution of complexes in the glomerulus. However,
the fact that a range of distribution of complexes
similar to that observed in experimental animals is also
seen in human renal specimens strongly suggests that
the same mechanisms are operating in human disease
[4]. Thus, almost all human immune complex glomer-
ulonephritis falls into one of two categories: diffuse
glomerular disease in which there is evidence of direct
penetration by complexes of the glomerular basement
membrane (in our experience accounting for 43% of
human immune complex glomerulonephritis) and mes-
angiopathic glomerulonephritis (accounting for 46%
of human immune complex glomerulonephritis), in
which immune complexes deposit primarily in the mes-
angium and only secondarily give rise to focal or
widely disseminated loop lesions.
In view of the recent recognition of the importance
of the latter pathway of glomerular injury, and of the
difficulty of recognizing its focal forms by light micros-
copy, a retrospective study of renal specimens ob-
tained during the last five years was undertaken to
identify those which gave evidence of focal mesangio-
pathic glomerulonephritis, to characterize the lesions
of this pattern of injury, and to correlate the morpho-
logical observations with the clinical diagnosis.
The materials studied consisted of all kidney speci-
mens obtained during a five-year period (1969 through
1973) which showed predominantly or almost exclu-
sively a mesangial localization of immune complexes
by immunofluorescence microscopy, thus excluding
cases of the disseminated form of mesangiopathic
glomerulohephritis. In addition to routine hematoxy-
lin-eosin staining and immunofluorescence microscopy
using reagents specific for human immunoglobulins A,
G and M, for C3, and for fibrin, most specimens were
also processed for examination by electron microscopy.
Evidence for the primary mesangial localization of
immune complexes characteristic of focal mesangio-
pathic glomerulonephritis was found in kidney speci-
mens from 42 patients (7% of the five-year sample)
with the following clinical diagnoses (Table 1): 1) Sys-
temic lupus: Biopsy specimens were obtained from
21 patients upon whom a clinical diagnosis of systemic
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Table 1.Light microscopic findings in cases of mesangiopathic glomerulonephritis of various etiologies, selected on the basis of
immunofluorescence microscopy
Clinical diagnosis Males
N
Females
N Ageyr
Light microscopic findings, N
Normal .Slight mesan- Marked mes- Focal
gial prolifera- angial prolif- GLNa
tion eration
Systemic lupus 1 20 6—39 4 6 1 10
Henoch-Schönlein syndrome 5 3 4—15 0 2 2 4
Intermittent hematuria 8 0 4—44 3 3 0 2
Chance proteinuria 3 2 15—39 2 3 0 0
GLN =glomerulonephritis.
lupus had been previously established. The patients
were normotensive and none showed nitrogen reten-
tion. While urine studies showed only microhematuria
and slight proteinuria in most of these patients, an
occasional patient showed marked proteinuria and
grosshematuria. 2) Henoch-Schönlein syndrome: Each
of these eight patients had one or more bouts of hem-
aturia, but no other urinary abnormalities. Biopsy
specimens were obtained during an episode of hema-
tuna. 3) Recurrent hematuria and chance proteinuria:
These 13 patients had shown either intermittent hem-
aturia of at least one year's duration or persistent
mild proteinuria. Except for these urinary abnormali-
ties, these patients were in good health.
The light microscopic appearance of the biopsy
specimens from the patients with systemic lupus varied
from normal (Fig. 1A) through slight or marked
mesangial cell proliferation (Fig. 1B) to focal glomeru-
lonephritis (Fig. IC). In the patients showing the more
severe alterations, eosinophilic amorphous material
was often seen infiltrating the centrilobular areas. In
such cases large clumps of material stainable by re-
agents specific for immunoglobulins and C3 were seen
in a similar location by immunofluorescence micros-
copy (Fig. 1D). In the less severe cases there was a
smaller amount of material deposited in the mesangial
areas. The extent of deposition of complexes in the
loop was minimal except in areas showing local changes
by light microscopy. The deposits were composed
mainly of IgG and C3 and usually, but to a lesser de-
gree, of the other immunoglobulins and fibrinogen.
Electron micrographs showed amorphous dense
material expanding the mesangium to varying degrees
and, in the case of the local lesions, extending into the
inner portion of the peripheral loop beneath the endo-
thelium (Fig. 2). No membranous or subepithelial de-
posits were seen.
The biopsy specimens from patients with Henoch-
Schonlein syndrome showed changes ranging from
slight to marked mesangial cell proliferation (Fig. 3A)
to focal glomerulonephritis. Immunofluorescence
microscopy showed immune complex deposits more
uniformly distributed throughout the mesangial area
than in the cases of systemic lupus. While such deposits
usually stained most intensely with reagents specific for
IgG (Fig. 3B), they frequently were visualized as
readily with reagents specific for IgA and for fibrino-
gen. In cases showing local ioop involvement by light
microscopy, deposits were also observed to extend to
a greater or lesser degree into the peripheral loops. The
electron microscopic finding paralleled those observed
by immunofluorescence. When the peripheral loops
were involved, electron-dense masses were observed
either intralumenally, in which case they were often
mixed with fibrin, or intramembranously, where they
formed bulging masses beneath the visceral epithelium
(Fig. 3C).
Using light microscopy, the glomeruli from 11 of the
13 patients with chance proteinuria or recurrent hem-
aturia either appeared normal or showed slight
mesangial cell proliferation (Fig. 4A). The biopsy
specimens of the remaining two patients showed focal
glomerulonephritis. Immunofluorescence microscopy
revealed numerous relatively small deposits scattered
throughout the mesangium with occasional extension
into the contiguous loop wall. In material from one
patient with intermittent hematuria, the deposits
stained strongly with reagents specific for both IgG
and IgA (Fig. 4B), as well as C3. In the remaining
specimens the deposits stained mainly with reagents
specific for IgG and C3, with variable amounts of stain-
ing for the remaining immunoglobulins. Electron
microscopy showed electron-dense deposits in a
similar distribution. When these deposits extended in-
to the loop, they were found on the inner aspect of the
basement membrane and fusion of the underlying epi-
thelial cell foot processes was observed in these areas
(Fig. 4C).
Focal mesangiopathic glomerulonephritis 219
Fig. 1. Systemic lupus (each figure from a different case): A, Glomerulus is essentially normal (hematoxylin-eosin, x 320). There may be a
modest increase in mesangial cells. Immunofluorescence and electron microscopy showed exclusively mesangial deposits consistent with
focal mesangiopathic glomerulonephritis. B, Marked centrilobular mesangial cell proliferation characteristic of focal mesangiopathic
glomerulonephritis (hematoxylin-eosin, x 320). C, Localized area of necrosis and cellular proliferation in a case of focal mesangiopathic
glomerulonephritis (hematoxylin-eosin, x 320). D, Glomerulus showing almost exclusively centrilobular mesangial immunofluorescent de-
posits from a case of focal mesangiopathic glomerulonephritis (immunofluorescence microscopy, antibody specific for IgG, x 390).
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Fig. 2. Systemic lupus: Electron micrograph showing opaque deposits in mesangium and inner aspects of contiguous loops (x 9,500). From
a case showing focal mesangiopathic glomerulonephritis by light microscopy.
Discussion
The present observations support our previous find-
ings that the basic morphological alteration in focal
glomerulonephritis is a result of the deposition of im-
mune complexes in the mesangium [12]. The local
nature of the light microscopic lesion is due to spillage
of the mesangial deposits into the peripheral loops.
Because of the prominent pathogenetic role of the
mesangium in the production of lesions associated
with focal immune complex glomerulonephritis, we
have designated this entity focal mesangiopathic gb-
merulonephritis. Since immunofluorescence micros-
copy is capable of detecting the mesanial localization
of immune complexes in renal specimens which appear
normal or only show slight changes by light micros-
copy, use of this technique is often required to estab-
lish a diagnosis of focal mesangiopathic glomerulo-
nephritis. Thus, in the present series only 38% of the
specimens showed local, focal lesions characteristic of
focal glomerulonephritis on light microscopy.
'J 
'I 
LA
S.
. 
.
,
s-
 
Focal mesangiopathic glomerulonephritis 221
Fig. 3. Henoch-Schönlein syndrome (eachfigurefrom a different case): A, Glomerulus showing proliferation of mesangial cells (heinaloxy.
lin-eosin, x 400). Immunofluorescence microscopy showed extensive mesangial deposits. B, Clumps of immune complex deposits confined
more or less exclusively to the mesangium (immunofluorescence microscopy, antibody specific for IgG, x 350). This section is taken at right
angles to the stalk. C, Electron-dense masses extending from the mesangium into the basement membrane (x 12,500). The endothelium is
intact. There is fusion of the epithelial cell foot processes.
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In general, immunofluorescence microscopy and
electron microscopy do not permit the differentiation
of the various diseases which may give rise to focal mes-
angiopathic glomerulonephritis. However, electron
micrographs of the lesions of Henoch-Schönlein
disease show characteristics which are highly suggestive
of that syndrome—namely bulging intramembranous
and intraluminal electron-dense deposits. Using im-
munofluorescence microscopy, the presence of large
amounts of complexes containing IgA in one of our
cases of recurrent hematuria is reminiscent of the cases
reported by Berger [13]. The remaining cases of recur-
rent hematuria stained most strongly with reagents
specific for IgG.
The whole range of changes possible in mesangio-
pathic glomerulonephritis can be seen in systemic
lupus. In addition, more information is available
about the immunological aspects of systemic lupus
than any other human disease which displays mesan-
giopathic lesions. Although patients with systemic lupus
may form antibodies to many tissue constituents, the
evidence strongly suggests that antibodies directed
against nuclear components and in particular native or
undenatured DNA play a major role in producing
glomerular lesions. DNA and antibody to DNA have
been detected in the glomerular lesions of systemic
lupus [14] and immune complexes containing DNA
have been found to circulate in some patients with
systemic lupus [15]. While information about the size
of the circulating complexes is not yet available, the
macromolecular nature of DNA suggests that the for-
mation of intermediate or larger sized complexes is
very likely. The presence of such complexes would be
consistent with the high percentage of mesangiopathic
lesions found in lupus glomerulonephritis.
Based on clinicopathological correlations, the
various stages of mesangiopathic lesions seen in cases
of systemic lupus are probably due to variation in the
rates of delivery of intermediate-size immune com-
plexes to the glomeruli. At low rates of delivery, such
complexes would be restricted to the mesangium and
give rise to a mesangiopathy. As the rate of delivery is
increased, the mesangium would be overloaded so that
both expansion of the mesangium at the expense of the
loop and subendothelial accumulation of complexes
would occur giving rise to focal or disseminated mes-
angiopathic glomerulonephritis.
Reprint requests to Dr. Frederick G, Germuth, Jr., Department
of Laboratory Medicine, St. John's Mercy Medical Center, St.
Louis, Missouri 63J41, U.S.A.
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Fig. 4. Intermittent hematuria: A, Essentially normal glomerulus (hematoxylin-eosin, x 350). B, Deposits essentially confined to the
mesangium (immunofluorescence microscopy, antibody specific for IgA, x 225). C, Small electron-dense deposits in mesangium (arrows) and
occasionally within loop (x 8,000). The sparse loop deposits are associated with fusion of the epithelial cell foot processes.
